SCHEMBL9034937

SCHEMBL9034937

CCCCCn1c(C=O)c(CCCC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.47
AGTR2 P50052 9/20 0.47
GP6 Q9HCN6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9035747 0.97 GP6 (0.47) AGTR1AGTR2GP6
SCHEMBL9036685 0.97 AGTR2 (0.46) AGTR1AGTR2GP6
SCHEMBL9035915 0.96 GP6 (0.47) AGTR1AGTR2GP6
SCHEMBL9035387 0.94 GP6 (0.46) AGTR1AGTR2GP6
SCHEMBL9035407 0.93 AGTR1 (0.49) AGTR1AGTR2GP6
SCHEMBL9035158 0.93 GP6 (0.48) AGTR1AGTR2GP6
SCHEMBL9554895 0.93 GP6 (0.48) AGTR1AGTR2GP6
SCHEMBL9035246 0.93 AGTR1 (0.43) AGTR1AGTR2GP6
SCHEMBL9035688 0.92 GP6 (0.44) AGTR1AGTR2GP6
SCHEMBL9704938 0.91 AGTR2 (0.40) AGTR1AGTR2GP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP claimed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO claimed
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP disclosed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed